What is the recommended dosage of nitrofurantoin macrocrystalline for treating a urinary tract infection?

Nitrofurantoin Macrocrystalline Dosing for UTI

For uncomplicated cystitis in adults, prescribe nitrofurantoin macrocrystals 100 mg orally twice daily for 5 days. 1, 2

Standard Dosing Regimen

• Dose: 100 mg orally twice daily 1, 2
• Duration: 5 days for women with uncomplicated cystitis 1, 2
• Alternative formulations: Nitrofurantoin monohydrate/macrocrystals or macrocrystals prolonged release can both be dosed at 100 mg twice daily for 5 days 1

The 5-day regimen achieves 90-93% clinical cure rates and 88-92% microbiological cure rates, matching the efficacy of longer courses while minimizing antibiotic exposure. 1, 2 This duration is endorsed by the Infectious Diseases Society of America (IDSA) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) as the optimal balance between efficacy and antimicrobial stewardship. 2

Duration Considerations

• 5-day course: Recommended standard duration with clinical cure rates of 90-93% 1, 2
• 7-day course: Achieves slightly higher cure rates (93-95%) but offers no clinically meaningful advantage over 5 days 1, 2
• 3-day course: Shows markedly lower cure rates (61-70%) and lacks robust supporting evidence 3, 4

The 5-day regimen is preferred because it provides equivalent efficacy to 7-day courses while reducing unnecessary antibiotic exposure. 1, 2

Special Populations

• Men with uncomplicated UTI: Extend duration to 7 days at 100 mg twice daily 2
• Older adults (≥65 years): Use the same dosing as younger adults (100 mg twice daily for 5 days) 2
• Alternative dosing (less common): 50-100 mg four times daily for 5-7 days is an older regimen that is less convenient 1

Efficacy Data

The 5-day nitrofurantoin regimen demonstrates:

• Clinical cure: 84-93% at early follow-up 1, 2
• Microbiological cure: 86-92% bacterial eradication 1, 2
• Comparable to trimethoprim-sulfamethoxazole: Similar clinical (93% vs 95%) and microbiological outcomes (88% vs 94%) 1
• Comparable to fosfomycin: Similar clinical cure (89-91% vs 91-95%) but superior microbiological cure (86% vs 78%) 1

Critical Contraindications

Do not use nitrofurantoin for:

• Pyelonephritis or upper tract infections: Poor tissue penetration makes it ineffective 1, 2
• Creatinine clearance <30 mL/min: Insufficient urinary concentrations are achieved 2, 5
• Late-term pregnancy (38-42 weeks): Risk of hemolytic anemia in the newborn 2, 5

Common Adverse Effects

• Nausea and headache: Occur in 5-28% of patients, generally mild and reversible 2, 5
• Pulmonary reactions: Chronic pulmonary hypersensitivity can occur with prolonged use (>6 months), presenting as dyspnea, cough, and interstitial pneumonitis 5
• Peripheral neuropathy: Rare but potentially irreversible, especially in patients with renal impairment, anemia, diabetes, or vitamin B deficiency 5
• Hepatic reactions: Hepatitis and cholestatic jaundice occur rarely 5

Clinical Advantages

• First-line status: Recommended as first-line therapy due to consistently low resistance rates despite decades of use 1, 2
• Antimicrobial stewardship: Spares broader-spectrum systemic antibiotics (fluoroquinolones, cephalosporins) for more serious infections 2
• Resistance profile: Maintains activity against multidrug-resistant uropathogens 6

Common Pitfalls to Avoid

• Do not prescribe for suspected pyelonephritis: Nitrofurantoin does not achieve adequate tissue levels for upper tract infections 1, 2
• Do not use 3-day courses: Insufficient evidence supports this duration, and cure rates are lower 3, 4
• Check renal function: Avoid in patients with CrCl <30 mL/min 2, 5
• Avoid prolonged prophylactic use without monitoring: Long-term use (>6 months) increases risk of chronic pulmonary reactions 5